Ian S. Mitchell
Heat Biologics (United States)(US)
Publications by Year
Research Areas
Hemophilia Treatment and Research, Platelet Disorders and Treatments, Chronic Myeloid Leukemia Treatments, Indigenous Health, Education, and Rights, PI3K/AKT/mTOR signaling in cancer
Most-Cited Works
- → Discovery and Preclinical Pharmacology of a Selective ATP-Competitive Akt Inhibitor (GDC-0068) for the Treatment of Human Tumors(2012)184 cited
- → The future of bypassing agents for hemophilia with inhibitors in the era of novel agents(2018)65 cited
- → Discovery of pyrrolopyrimidine inhibitors of Akt(2010)55 cited
- → Discovery and SAR of spirochromane Akt inhibitors(2011)42 cited
- → PERSEPT 1: a phase 3 trial of activated eptacog beta for on‐demand treatment of haemophilia inhibitor‐related bleeding(2017)39 cited
- → Discovery of dihydrothieno- and dihydrofuropyrimidines as potent pan Akt inhibitors(2010)37 cited
- → Impacts of Planning Rules, Regulations, Uncertainty and Delay on Residential Property Development